<!DOCTYPE html><html lang="en"><head><meta charset="UTF-8"><meta name="viewport" content="width=device-width, initial-scale=1.0"><title>UC research targets dozens of incurable diseases – WATU</title><link rel="stylesheet" href="/styles.css"></head><body><header><h1 style="font-family: 'Arial Black', Gadget, sans-serif;font-style: italic;font-weight: 900;text-transform: uppercase;">We Are The University    </h1><nav><ul><li><a href="/">Home</a></li><li><a href="/about">About</a></li><li><a href="/contact">Contact</a></li><li><a href="/blog">Blog</a></li><li><a href="/archive">Archive</a></li><li><a href="/authors">Authors</a></li><li><a href="/games">Games</a></li><li><a href="/reading-groups">Reading Groups</a></li></ul></nav></header><main><h2>UC research targets dozens of incurable diseases</h2><h3><span>university-of-canterbury</span></h3><p>Mon Feb 20 2017 13:00:00 GMT+1300 (New Zealand Daylight Time)</p><p><h1>UC research targets dozens of incurable diseases</h1>
<p><strong>Monday, 20 February 2017, 10:56 am</strong><br><strong>Press Release: <a href="https://info.scoop.co.nz/University_of_Canterbury">University of Canterbury</a></strong></p>
<p><strong>UC research targets dozens of incurable diseases</strong></p>
<p>University of Canterbury researchers are working on a revolutionary drug-targeting system that could one day be used to treat a range of fatal, inherited diseases caused by genetic enzyme deficiencies.</p>
<p>With the aid of a Marsden Grant for $870,000, they’re focusing on around 60 or 70 incurable diseases called the lysosomal storage disorders, of which there are around 200 sufferers in New Zealand.</p>
<p>UC Chemistry Professor Antony Fairbanks says the system could deliver recombinant enzymes and other drugs to a specific organelle (a structure in a cell that performs a specialised function) within human cells, where they are needed.</p>
<p>“The key aspect of our research is to develop organelle targeting so we can specifically deliver enzymes and other drugs to where they need to be to do their job.”</p>
<p><strong>Professor Antony Fairbanks,</strong> Biomolecular Interaction Centre/Chemistry, University of Canterbury, on his research project, <em>A New Paradigm for Organelle Targeting</em>:</p>
<p><a href="https://youtu.be/PCOEuulGhic">https://youtu.be/PCOEuulGhic</a></p>
<p>ends</p>
<p>Advertisement - scroll to continue reading</p>
<p><a href="http://www.scoop.co.nz/about/terms.html">© Scoop Media</a>  </p>
<p>Advertisement - scroll to continue reading</p>
<p>a.supporter:hover {background:#EC4438!important;} @media screen and (max-width: 480px) { #byline-block div.byline-block {padding-right:16px;}}</p>
<h3>Using Scoop for work?</h3>
<p>Scoop is free for personal use, but you’ll need a licence for work use. This is part of our Ethical Paywall and how we fund Scoop. Join today with plans starting from less than $3 per week, plus gain access to exclusive <em>Pro</em> features.  </p>
<p><a href="https://pro.scoop.co.nz/Individual/?from=ProIn24">Join Pro Individual</a> <a href="https://pro.scoop.co.nz/using-scoop-for-work/?from=ProIn24">Find out more</a></p>
<p>Find more from <a href="https://info.scoop.co.nz/University_of_Canterbury">University of Canterbury</a> on InfoPages.</p>
</p></main><footer style="margin-top: 2rem; background: #0001; padding: 2rem; text-align: center;"><p>We Are The University</p><ul style="list-style-type: none; padding: 0; margin: 0;"><li><a href="/">Home</a></li><li><a href="/about">About</a></li><li><a href="/contact">Contact</a></li></ul></footer></body></html>